AIM ImmunoTech closes rights offering raising $1.8M; issues Series G Preferred and warrants

AIM ImmunoTech Inc.

Gross proceeds of approximately $1.8 million from 1,842 units in rights offering.
Each unit consists of one share of Series G Convertible Preferred Stock convertible at $1.00 per share.
Each unit includes 2 Class G Warrants exercisable at $1.00 per share, expiring in five years.
Series G Preferred has limited voting rights and pari passu liquidation preference with common stock.
Conversion capped at 4.99% beneficial ownership, adjustable to 9.99% with notice.

item 1.01 item 3.03 item 5.03 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.